Znn3bq.jpeg
²é¿´: 1824  |  »Ø¸´: 9
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

Ãγ¾ÒÝ

гæ (³õÈëÎÄ̳)

[ÇóÖú] ÇóÖú£¬ÕâÑù˵ÎÄÕÂÄܲ»Äܱ»½ÓÊÜ£¿

±¾ÈËǰһ¶Îʱ¼äÔÚinternational immunopharmacologyÉÏÍ·ÁËһƪÎÄÕ£¬Ó°ÏìÒò×Ó²»¸ß2.3°É£¬Éó¸åÒâ¼û»ØÀ´ÁË£¬ÓÐÒ»¸öÉó¸åÈ˾ÍÌáÁË3¸öÎÊÌ⣬»¹¶¼ÊÇСÎÊÌ⣬»ù±¾Ã»Ê²Ã´Ê£¬²»¹ýÁíÒ»¸öÉó¸åÈËÈ´ÊÇÕâô˵µÄ
Reviewer #2: The authors of this study claimed that synergistic effects of blocking IL-1beta and IL-17A could suppress the rheumatoid development in CIA mouse model.  Blocking of IL-1 and IL-17signaling pathway have been shown playing function in delaying or preventing the development of rheumatoid arthritis. In this study, the authors did not point out any new information in addition to well-documented. Detailed mechanism on how those two molecules play a synergistic effect is more favored.
And there are also several other questions.
1. The whole experiment was done in DBA mice, why humanized antibodies were used? Please justify the structural similarity of both human and murine IL-1 beta and IL-17A as well as the crossreactivities of those blocking antibody.
2. In 3.4 and 3.5, as author stated, it should be ex vivo experiment but not in vitro.

ÇóÖú´óÉñÃÇÕâÖÖÒâ¼ûÓ¦¸ÃÔõô°ìÄØ£¬ÎÊÌâÑϲ»ÑÏÖØ°¡£¿ÎÒ×îºÃÔõô»Ø´ðËû£¬ÒѾ­À§ÈźþÃÁË
»Ø¸´´ËÂ¥

» ÊÕ¼±¾ÌûµÄÌÔÌûר¼­ÍƼö

decision in progress

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

nuaawq

ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
ÈÏÕæÈ¥¸ÄµÄ»° Ï£ÍûºÜ´ó °¡¡£¡£¡£¡£¡£¡£
6Â¥2012-11-19 21:12:32
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 10 ¸ö»Ø´ð

Ãγ¾ÒÝ

гæ (³õÈëÎÄ̳)

×Ô¼º¶¥Ï£¬¹òÇóÒâ¼û
2Â¥2012-11-19 16:29:25
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

nono2009

³¬¼¶°æÖ÷ (ÎÄѧ̩¶·)

No gains, no pains.

ÓÅÐãÇø³¤ÓÅÐãÇø³¤ÓÅÐãÇø³¤ÓÅÐãÇø³¤ÓÅÐã°æÖ÷

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
±à¼­ÈÃÄã¸Ä£¬ËµÃ÷Ï£ÍûºÜ´ó¡£ºÃºÃ¸Ä£¬²»ÄܸÄÒ²ºÃºÃ½âÊÍ
3Â¥2012-11-19 19:42:59
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

xianjin1985

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
¸Ð¾õÓ¦¸Ã»áÓлú»á±»½ÓÊÜ£¬Ö»ÒªÈÏÕæÈ¥¸Ä£¬²¢ÇÒ¶ÔµÚ¶þ¸öÉó¸åÈ˵ÄÒâ¼ûÊʵ±½ÓÊÜ£¬¿´×Ô¼ºÔõô¸ÄÁ˰É
4Â¥2012-11-19 20:15:38
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ÉúÎïѧѧ˶£¬³õÊÔ351·Ö£¬Çóµ÷¼Á +4 ¡­¡«¡¢Íõ¡­¡« 2026-04-08 5/250 2026-04-08 21:49 by limeifeng
[¿¼ÑÐ] 368»¯Ñ§Çóµ÷¼Á +12 wwwwabcde 2026-04-07 13/650 2026-04-08 20:48 by LiuXingYuÐÇÐÇ
[¿¼ÑÐ] 324Çóµ÷¼Á +17 ÏëÉÏѧÇóµ÷ 2026-04-03 17/850 2026-04-08 20:04 by ÎÒ¼õ·Ê1
[¿¼ÑÐ] 306Çóµ÷¼Á +3 15287505595 2026-04-03 3/150 2026-04-07 18:08 by À¶ÔÆË¼Óê
[¿¼ÑÐ] ÉúÎïµ÷¼Á +5 ³È×Ó³È×Ó³È×Ó°¡ 2026-04-05 9/450 2026-04-07 15:31 by Éϰ¶¿ì¿ì
[¿¼ÑÐ] 325 µ÷¼Á +6 QQСϺ 2026-04-07 6/300 2026-04-07 15:17 by Ccclqqq
[¿¼ÑÐ] £¨µ÷¼Á£©Ò»Ö¾Ô¸±¨¿¼¹þ¶û±õ¹¤Òµ´óѧ0857×ÊÔ´Óë»·¾³×¨Òµ378·Ö¿¼Éú +7 ºÝºÝ¼ÓÓÍ 2026-04-05 8/400 2026-04-06 16:52 by momoð©
[¿¼ÑÐ] Çóµ÷¼Á +4 wos666 2026-04-03 5/250 2026-04-06 15:22 by wos666
[¿¼ÑÐ] ÉúÎïѧÇóµ÷¼Á +5 15064154688 2026-04-03 5/250 2026-04-06 11:56 by lijunpoly
[¿¼ÑÐ] 0860 Çóµ÷¼Á Ò»Ö¾Ô¸¹ú¿Æ´ó 348 ·Ö +3 WiiiP 2026-04-03 3/150 2026-04-05 17:43 by Ecowxq666£¡
[¿¼ÑÐ] ÉúÎïѧ308·ÖÇóµ÷¼Á£¨Ò»Ö¾Ô¸»ª¶«Ê¦´ó£© +8 ÏàÐűػá¹ââÍòÕ 2026-04-05 10/500 2026-04-05 12:19 by Hdyxbekcb
[¿¼ÑÐ] 083200 333Çóµ÷¼Á +3 Ê®¶þ£¡£¡ 2026-04-04 3/150 2026-04-05 08:28 by barlinike
[¿¼ÑÐ] 290Çóµ÷¼Á +7 luoziheng 2026-04-04 7/350 2026-04-04 23:17 by lqwchd
[¿¼ÑÐ] µ÷¼Á +9 19945159693 2026-04-03 10/500 2026-04-04 20:16 by dongzh2009
[¿¼ÑÐ] Ò»Ö¾Ô¸»¦985£¬326·ÖÇóµ÷¼Á +3 Áõīī 2026-04-03 3/150 2026-04-04 11:16 by ±¯É˵ÄÓóÍ·
[¿¼ÑÐ] ²ÄÁÏרҵ383Çóµ÷¼Á +8 ¹ùÑôÑôÑô³É 2026-04-03 8/400 2026-04-04 10:29 by Rednal.
[¿¼ÑÐ] ѧ˶288µ÷¼Á!!! +3 СÍõxw123 2026-04-03 3/150 2026-04-03 21:20 by à£à£à£0119
[¿¼ÑÐ] 294Çóµ÷¼Á +6 Grey_Ey 2026-04-03 6/300 2026-04-03 20:46 by ÐÀϲ777
[¿¼ÑÐ] ÍÁľˮÀû328·ÖÇóµ÷¼Á +6 ¼²·çÖª¾¢²Ý666 2026-04-02 6/300 2026-04-03 11:38 by znian
[¿¼ÑÐ] Çóµ÷¼Á +3 ÐÄÏëÊÂ³É¿É 2026-04-03 3/150 2026-04-03 11:22 by wangjy2002
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û